{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:09Z","timestamp":1746417729833,"version":"3.40.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006312","name":"South African Agency for Science and Technology Advancement","doi-asserted-by":"crossref","award":["113138"],"award-info":[{"award-number":["113138"]}],"id":[{"id":"10.13039\/501100006312","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Migraine during pregnancy is common and has been reported to affect up to 10% of pregnancies. Irrespective of the type of migraine, over the counter (OTC) painkillers are used as a migraine treatment plan. Growing evidence suggests that OTC painkillers have effects on the mother, the child and hypertensive disorders of pregnancy, including hypertension, eclampsia and pre-eclampsia, but inconsistent findings have been reported. The aim of this study is therefore to investigate the association between the use of migraine OTC painkillers and hypertensive disorders during pregnancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Databases such as Pubmed, Cochrane library, ScienceDirect and google scholar will be searched to identify eligible studies. Studies will be included if they are randomised controlled trials, cohort, and matched cohort, and cross-sectional studies of pregnant women with reported use of OTC painkillers to treat migraines at any stage of their pregnancy. The results will be reported based on the preferred reporting items for systematic reviews and meta-analysis 2009 statement, and article screening and selection process will also be demonstrated through a preferred reporting items for systematic reviews and meta-analysis for protocols flow diagram. The data will then be extracted by 1 reviewer and checked by another for accuracy. The quality and risk of bias of eligible studies will be performed by both reviewers using the Hoy tool and grading of recommendations assessment, development and evaluation tool. The data will be analysed using Review Manager 5.3 (RevMan 5.3) software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>The review and meta-analysis will not require ethical approval and the findings will be published in peer-reviewed journals and presented at local and international conferences. Findings from this study will help to improve knowledge on the understanding of the effects OCT on hypertensive disorders of pregnancy. This study will also provide new information on the management of migraine during pregnancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Systematic review registration:<\/jats:title>\n            <jats:p>International prospective Register of Systematic Reviews (PROSERO) number: CRD42021232232.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028049","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:07:40Z","timestamp":1639141660000},"page":"e28049","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Interrelationships between migraine over the counter (OTC) painkillers and hypertensive disorders of pregnancy"],"prefix":"10.1097","volume":"100","author":[{"given":"Shalati L.","family":"Nkuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7769-4528","authenticated-orcid":false,"given":"Wendy N.","family":"Phoswa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1517\/14740338.2010.505601","article-title":"Migraine therapy during pregnancy and lactation","volume":"9","author":"Cassina","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","article-title":"The global burden of headache: a documentation of headache prevalence and disability worldwide","volume":"27","author":"Stovner","year":"2007","journal-title":"Cephalalgia"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s10194-017-0816-0","article-title":"Headache and pregnancy: a systematic review","volume":"18","author":"Negro","year":"2017","journal-title":"J Headache Pain"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.18773\/austprescr.2012.023","article-title":"Hypertensive disorders of pregnancy","volume":"35","author":"Donovan","year":"2012","journal-title":"Aust Prescr"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/jmwh.12725","article-title":"Hypertensive disorders of pregnancy: overview and current recommendations","volume":"63","author":"Folk","year":"2018","journal-title":"J Midwifery Womens Health"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/s12884-017-1399-0","article-title":"Patterns and predictors of analgesic use in pregnancy: a longitudinal drug utilization study with special focus on women with migraine","volume":"17","author":"Harris","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/14767050903334877","article-title":"Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: a birth cohort study","volume":"23","author":"Rebordosa","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"BMJ"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/138920012800166607","article-title":"Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn","volume":"13","author":"Antonucci","year":"2012","journal-title":"Curr Drug Metab"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/AOG.0000000000002979","article-title":"Nonsteroidal antiinflammatory drug administration and postpartum blood pressure in women with hypertensive disorders of pregnancy","volume":"132","author":"Anastasio","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejogrb.2005.09.013","article-title":"Antihypertensive therapy in patients with pre-eclampsia: a prospective randomised multicentre study comparing dihydralazine with urapidil","volume":"127","author":"Wacker","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: US Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100\u200amg) used for prevention of pre-eclampsia in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re\u2013Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Uomo","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1186\/1471-2288-11-22","article-title":"Dealing with substantial heterogeneity in Cochrane reviews. Cross-sectional study","volume":"11","author":"Schroll","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/head.12206","article-title":"Lifetime prevalence and correlates of migraine among women in a pacific northwest pregnancy cohort study","volume":"54","author":"Frederick","year":"2014","journal-title":"Headache"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1524-6175.2001.00458.x","article-title":"Working group report on high blood pressure in pregnancy","volume":"3","author":"Moser","year":"2001","journal-title":"J Clin Hypertens"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13311-017-0592-1","article-title":"Migraine treatment: current acute medications and their potential mechanisms of action","volume":"15","author":"Ong","year":"2018","journal-title":"Neurotherapeutics"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.4103\/0250-474X.51941","article-title":"Drug use in pregnancy; a point to ponder!","volume":"71","author":"Sachdeva","year":"2009","journal-title":"Indian J Pharm Sci"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4314\/ahs.v20i3.24","article-title":"Medication use among pregnant women at a secondary health institution: utilisation patterns and predictors of quantity","volume":"20","author":"Obadeji","year":"2020","journal-title":"Afr Health Sci"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fpubh.2020.00028","article-title":"Beliefs and risk awareness on medications among pregnant women attending the antenatal care unit in Ethiopia University Hospital. Overestimating the risks is another dread","volume":"8","author":"Tefera","year":"2020","journal-title":"Front Public Health"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:08:16Z","timestamp":1746335296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028049"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":28,"journal-issue":{"issue":"49","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028049","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"assertion":[{"value":"2021-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}